Close

Citi Upgrades Travere Therapeutics (TVTX) to Buy

December 5, 2023 6:54 AM EST Send to a Friend
(Updated - December 5, 2023 6:55 AM EST)

Citi analyst Carly Kenselaar upgraded Travere Therapeutics (NASDAQ: TVTX) from Neutral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login